Study Finds Discontinuation Of Rosiglitazone Left Many Diabetes Patients Without Good Glycemic Control

Podiatry Arena Study Finds Discontinuation Of Rosiglitazone Left Many Diabetes Patients Without Good Glycemic Control

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Study Finds Discontinuation Of Rosiglitazone Left Many Diabetes Patients Without Good Glycemic Control

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

15th April 2009, 05:40 AM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,121

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 19 Times in 19 Posts

Study Finds Discontinuation Of Rosiglitazone Left Many Diabetes Patients Without Good Glycemic Control

Podiatry Arena members do not see these ads

When concerns were raised about the safety of the diabetes medication, rosiglitazone, in May 2007, many patients and their doctors made the decision to discontinue use of the drug. A study published in Endocrine Practice by Dr. Etta Fanning from the University of Texas Health Science Center along with her colleagues reported that many patients who discontinued use of rosiglitazone received less therapy and higher blood glucose levels as a result.

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Running May Provide More Benefits To Bones Than Resistance Training, MU Study Finds	RSSFeedBot	Latest Sports Medicine News	0	2nd March 2009 07:20 AM
Pre-Activity Stretching May Hinder Athletic Performance, Unlv Study Finds	RSSFeedBot	Latest Sports Medicine News	0	22nd September 2008 05:20 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 07:12 AM.

User Name		Remember Me?
Password